Brainsway Release: Results Announced For Study Of Major Depression Patients Who Did Not Respond To Medication Treatments

JERUSALEM, June 5, 2014 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to announce the final results for a study examining the safety and effectiveness of Brainsway's technology for treating major depressive disorder patients (the "Study") who did not respond to medication treatments, held at the Douglas Mental Health Institute of McGill University in Canada.

Help employers find you! Check out all the jobs and post your resume.